...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Rumors starting again

Posted question for AGM Does management have a clear plan for company and if nor and we continue as an academic exercise will they give shareholders liquidity through a Public listing.

Share
New Message
Please login to post a reply